Citius Pharmaceuticals, Inc. (CTXR)
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections by salvaging the infected catheter; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a corticosteroid-lidocaine topical formulation that intends to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome; and I/ONTAK, an engineered IL-2 diphtheria toxin fusion protein for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
$99.06M
Mr. Leonard L. Mazur
21.00
Cranford, NJ
Aug 03, 2017
-2.28
$-0.24
4.31
6.75
0.00%
-2.49
-0.57
1.11
0.00
6.75
-39.44%
-44.97%
Similar stocks (14)
ImmunityBio, Inc.
IBRX
Ardelyx, Inc.
ARDX
Day One Biopharmaceuticals, Inc.
DAWN
Terns Pharmaceuticals, Inc.
TERN
Lexicon Pharmaceuticals, Inc.
LXRX
Inozyme Pharma, Inc.
INZY
Seres Therapeutics, Inc.
MCRB
HOOKIPA Pharma Inc.
HOOK
Acumen Pharmaceuticals, Inc.
ABOS
X4 Pharmaceuticals, Inc.
XFOR
Fortress Biotech, Inc.
FBIO
Eyenovia, Inc.
EYEN
Ocuphire Pharma, Inc.
OCUP
Galera Therapeutics, Inc.
GRTX
ETF Exposure (8)
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (14)
ImmunityBio, Inc.
IBRX
Ardelyx, Inc.
ARDX
Day One Biopharmaceuticals, Inc.
DAWN
Terns Pharmaceuticals, Inc.
TERN
Lexicon Pharmaceuticals, Inc.
LXRX
Inozyme Pharma, Inc.
INZY
Seres Therapeutics, Inc.
MCRB
HOOKIPA Pharma Inc.
HOOK
Acumen Pharmaceuticals, Inc.
ABOS
X4 Pharmaceuticals, Inc.
XFOR
Fortress Biotech, Inc.
FBIO
Eyenovia, Inc.
EYEN
Ocuphire Pharma, Inc.
OCUP
Galera Therapeutics, Inc.
GRTX
ETF Exposure (8)
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%